Sabra Healthcare REIT (NASDAQ:SBRA) Lowered to “Hold” Rating by Truist Financial

Truist Financial cut shares of Sabra Healthcare REIT (NASDAQ:SBRA) from a buy rating to a hold rating in a research note released on Wednesday morning, MarketBeat Ratings reports.

SBRA has been the subject of a number of other reports. Wells Fargo & Company raised their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Weiss Ratings downgraded Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Barclays began coverage on Sabra Healthcare REIT in a research note on Tuesday. They set an “overweight” rating and a $21.00 price target on the stock. Cantor Fitzgerald raised their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Finally, UBS Group set a $19.00 price objective on Sabra Healthcare REIT in a research report on Thursday, June 18th. Five equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $21.45.

Sabra Healthcare REIT Stock Down 0.1%

SBRA opened at $20.03 on Wednesday. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. The firm’s fifty day moving average price is $19.70 and its two-hundred day moving average price is $19.69. Sabra Healthcare REIT has a fifty-two week low of $17.17 and a fifty-two week high of $21.28. The company has a market capitalization of $5.05 billion, a P/E ratio of 31.79, a P/E/G ratio of 1.50 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same period in the prior year, the firm posted $0.37 EPS. Sabra Healthcare REIT’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, analysts anticipate that Sabra Healthcare REIT will post 1.5 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a $0.30 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Rothschild Investment LLC grew its holdings in shares of Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in Sabra Healthcare REIT by 97.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 714 shares during the last quarter. Founders Capital Management bought a new stake in Sabra Healthcare REIT during the 3rd quarter worth about $28,000. Strengthening Families & Communities LLC acquired a new position in Sabra Healthcare REIT during the fourth quarter valued at approximately $29,000. Finally, Versant Capital Management Inc boosted its position in Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 603 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.